1. Home
  2. PVLA vs EXFY Comparison

PVLA vs EXFY Comparison

Compare PVLA & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • EXFY
  • Stock Information
  • Founded
  • PVLA 2015
  • EXFY 2008
  • Country
  • PVLA United States
  • EXFY United States
  • Employees
  • PVLA N/A
  • EXFY N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • EXFY Computer Software: Prepackaged Software
  • Sector
  • PVLA Health Care
  • EXFY Technology
  • Exchange
  • PVLA Nasdaq
  • EXFY Nasdaq
  • Market Cap
  • PVLA 253.2M
  • EXFY 206.1M
  • IPO Year
  • PVLA N/A
  • EXFY 2021
  • Fundamental
  • Price
  • PVLA $22.30
  • EXFY $2.40
  • Analyst Decision
  • PVLA Strong Buy
  • EXFY Strong Buy
  • Analyst Count
  • PVLA 7
  • EXFY 3
  • Target Price
  • PVLA $46.29
  • EXFY $4.75
  • AVG Volume (30 Days)
  • PVLA 81.8K
  • EXFY 444.1K
  • Earning Date
  • PVLA 08-15-2025
  • EXFY 08-07-2025
  • Dividend Yield
  • PVLA N/A
  • EXFY N/A
  • EPS Growth
  • PVLA N/A
  • EXFY N/A
  • EPS
  • PVLA N/A
  • EXFY N/A
  • Revenue
  • PVLA N/A
  • EXFY $141,775,000.00
  • Revenue This Year
  • PVLA N/A
  • EXFY $7.77
  • Revenue Next Year
  • PVLA N/A
  • EXFY $5.45
  • P/E Ratio
  • PVLA N/A
  • EXFY N/A
  • Revenue Growth
  • PVLA N/A
  • EXFY N/A
  • 52 Week Low
  • PVLA $11.17
  • EXFY $1.26
  • 52 Week High
  • PVLA $29.27
  • EXFY $4.13
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • EXFY 51.05
  • Support Level
  • PVLA N/A
  • EXFY $2.19
  • Resistance Level
  • PVLA N/A
  • EXFY $2.33
  • Average True Range (ATR)
  • PVLA 0.00
  • EXFY 0.11
  • MACD
  • PVLA 0.00
  • EXFY 0.02
  • Stochastic Oscillator
  • PVLA 0.00
  • EXFY 69.01

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.

Share on Social Networks: